Axsome Therapeutics, Inc. (AXSM) - Yahoo Finance

Find the latest Axsome Therapeutics, Inc. (AXSM) stock quote, history, news and other vital information to help you with your stock trading and investing.

$80.05
OFF

Axsome Therapeutics Stock Price Today (NASDAQ: AXSM) Quote, …

2 weeks from now

5 days ago · With Axsome Therapeutics stock trading at $80.05 per share, the total value of Axsome Therapeutics stock (market capitalization) is $3.88B. ... (NASDAQ: AXSM) Axsome …

wallstreetzen.com

$134.07
OFF

AXSM / Axsome Therapeutics, Inc. (NasdaqGM) - Forecast, Price

2 weeks from now

AXSM / Axsome Therapeutics, Inc. (NasdaqGM) - Forecast, Price Target, Estimates, Predictions ... The average one-year price target for Axsome Therapeutics, Inc. is $134.07. The forecasts …

fintel.io

3%
OFF

Axsome Therapeutics (NASDAQ:AXSM) Shares Up 5.3% Following …

2 weeks from now

4 hours ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price traded up 5.3% during trading on Monday after Truist Financial raised their price target on the …

etfdailynews.com

$125.00
OFF

Axsome Therapeutics (AXSM) Gets A Buy From TD Cowen

2 weeks from now

1 day ago · In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a price target of $125.00. The …

businessinsider.com

5%
OFF

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

2 weeks from now

20 hours ago · Axsome Therapeutics (AXSM) shares ended the last trading session 11.5% higher at $89.27. The jump came on an impressive volume with a higher-than-average number of …

yahoo.com

$89.27
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected To …

2 weeks from now

1 day ago · Axsome Therapeutics stock opened at $89.27 on Monday. Axsome Therapeutics has a 12 month low of $64.11 and a 12 month high of $105.00. The business’s fifty day simple …

etfdailynews.com

3%
OFF

Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.3% On

2 weeks from now

2 days ago · Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report)'s share price rose 5.3% during trading on Monday after Truist Financial raised their price target on the stock from …

marketbeat.com

$133.00
OFF

Axsome Therapeutics' (AXSM) "Buy" Rating Reaffirmed At …

2 weeks from now

1 day ago · Needham & Company LLC reissued a "buy" rating and issued a $133.00 target price on shares of Axsome Therapeutics in a report on Monday. ... Axsome Therapeutics …

marketbeat.com

87%
OFF

Axsome Therapeutics (AXSM) Market Capitalization Overview

2 weeks from now

1 day ago · As of Jan 14, 2025, Axsome Therapeutics (AXSM) has a market capitalization of $4.10B.Over the past 30 days, its market cap has decreased by -11.87%, while in the last 12 …

public.com

FAQs about Axsome Therapeutics, Inc. (AXSM) - Yahoo Finance Coupon?

What does Axsome Therapeutics Inc (axsm) do?

The Company focuses on developing therapies for pain, neurological disorders, and other central nervous system. Axsome Therapeutics serves patients worldwide. Stock analysis for Axsome Therapeutics Inc (AXSM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ...

Where can I buy Axsome Therapeutics stock?

Shares of AXSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Axsome Therapeutics own? ...

Should you buy axsm (axsm) stock?

Losses were -$239.24 million, 27.8% more than in 2022. According to 14 analysts, the average rating for AXSM stock is "Strong Buy." The 12-month stock price forecast is $125.93, which is an increase of 39.77% from the latest price. ...

How much did Axsome Therapeutics (axsm) raise?

Axsome Therapeutics (AXSM) raised $52 million in an initial public offering on Thursday, November 19th 2015. The company issued 4,300,000 shares at a price of $11.00-$13.00 per share. Ladenburg Thalmann and Cantor Fitzgerald & Co. served as the underwriters for the IPO and Brean Capital was co-manager. ...

Who owns Axsome Therapeutics?

Mirae Asset Global Investments Co. Ltd. boosted its holdings in Axsome Therapeutics by 22.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,736 shares of the company’s stock valued at $156,000 after acquiring an additional 318 shares during the period. ...

What is Axsome (axsm)?

NasdaqGM - NasdaqGM Real-time price. Currency in USD Axsome (AXSM) doses the first patient in the phase III PARADIGM study evaluating Sunosi (solriamfetol) for treating major depressive disorder. The stock rises 6%. ...